Results 101 to 110 of about 34,162 (142)

Attenuation of neurological deficit by a novel ethanolamine derivative in rats after brain trauma. [PDF]

J Exp Pharmacol, 2019
Sysoev YI, Uzuegbunam BC, Okovityi SV.
europepmc   +1 more source

Nanotechnology approaches to drug delivery for the treatment of ischemic stroke. [PDF]

Bioact Mater
Peng B, Mohammed FS, Tang X, Liu J, Sheth KN, Zhou J.   +5 more
europepmc   +1 more source

Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review. [PDF]

Eur Psychiatry
Melillo A, Perrottelli A, Caporusso E, Coltorti A, Giordano GM, Giuliani L, Pezzella P, Bucci P, Mucci A, Galderisi S, Maj M.   +10 more
europepmc   +1 more source

Pharmacological Effects of Humic Substances and Their Signaling Mechanisms. [PDF]

Molecules
Zykova MV, Trofimova ES, Azarkina LA, Lasukova TV, Mihalyov DA, Drygunova LA, Danilets MG, Ligacheva AA, Tsupko AV, Bashirov SR, Belousov MV.   +10 more
europepmc   +1 more source

Interventions for Long COVID: A Narrative Review. [PDF]

J Gen Intern Med
Ivlev I, Wagner J, Phillips T, Treadwell JR.   +3 more
europepmc   +1 more source

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Analysis of the Russian Database of Spontaneous Reports. [PDF]

Pharmaceuticals (Basel)
Zyryanov S, Asetskaya I, Butranova O, Terekhina E, Polivanov V, Yudin A, Samsonova K.   +6 more
europepmc   +1 more source

Program with last minute abstracts of the Padua Days on Muscle and Mobility Medicine, 27 February - 2 March, 2024 (2024Pdm3). [PDF]

Eur J Transl Myol
Zampieri S, Bersch I, Smeriglio P, Barbieri E, Boncompagni S, Maccarone MC, Carraro U.   +6 more
europepmc   +1 more source